DCDavid A. Copland

David A. Copland

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


David A. Copland has a total of 115 co-authors. Here are the top co-authors by number of shared publications:

  • Andrew D. Dick

    Academic Unit of Ophthalmology, Translational Health Sciences, University of Bristol, Bristol, United Kingdom

    5 shared publications
  • Colin J. Chu

    Academic Unit of Ophthalmology, Translational Health Sciences, University of Bristol, Bristol, United Kingdom

    5 shared publications
  • Andrew D. Dick

    Academic Unit of Ophthalmology, Bristol Medical School, University of Bristol, Bristol, BS8 1TD, UK; School of Cellular and Molecular Medicine, University of Bristol, Bristol, BS8 1TD, UK; Institute of Ophthalmology, University College London, London, EC1V 9EL, UK; National Institute of Health Research (NIHR) Moorfields Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, EC1V 2PD, UK

    4 shared publications
  • Oliver Hugh Bell

    Academic Unit of Ophthalmology, Bristol Medical School, University of Bristol, Bristol BS8 1TD, UK

    3 shared publications
  • Alison J. Clare

    Academic Unit of Ophthalmology, Translational Health Sciences, University of Bristol, BS8 1TD Bristol, UK; NIHR Biomedical Research Centre of Ophthalmology, Moorfields Eye Hospital, EC1V 2PD London, UK; School of Cellular and Molecular Medicine, University of Bristol, BS8 1TD Bristol, UK

    2 shared publications
  • Amy Ward

    Academic Unit of Ophthalmology, Bristol Medical School, University of Bristol, Bristol, BS8 1TD, UK

    2 shared publications

Latest Publications

  • Open Access

    Microglia-independent rAAV-induced inflammation causes persistent ocular immune dysregulation rescued by S1P receptor modulation

    by Philip M. Langer, Alison J. Clare, Xudong Peng, Katherine L. Costello, Suci Cendanawati, Leslie L. Wilson, Amy Ward, Oliver H. Bell, Colin J. Chu, Ying Kai Chan, et al.


  • Open Access

    IL-23 drives uveitis by acting on a population of tissue-resident entheseal T cells

    by Robert Hedley, Amy Ward, Colin J. Chu, Sarah E. Coupland, Serafim Kiriakidis, Peter C. Taylor, Stephanie G. Dakin, ORBIT Research Consortium, Christopher D. Buckley, Jonathan Sherlock, et al.

    Recurrent acute anterior uveitis is a frequent extra-articular manifestation of the axial spondyloarthropathies (AxSpA): chronic inflammatory diseases affecting the spine, enthesis, peripheral joints, skin, and gastrointestinal tract. Pathology in AxSpA has been associated with local tissue-resident populations of IL-23 responsive lymphoid cells. Here we characterize a population of ocular T cell defined by CD3 + CD4 – CD8 – CD69 + γδTCR + IL-23R + that reside within the anterior uvea as an ocular entheseal analogue of the mouse eye. Localized cytokine expression demonstrates that uveal IL-23R + IL-17A–producing cells are both necessary and sufficient to drive uveitis in response to IL-23. This T cell population is also present in humans, occupying extravascular tissues of the anterior uveal compartment. Consistent with the concept of IL-23 as a unifying mediator in AxSpA, we present evidence that IL-23 can also act locally on tissue resident T cells in the anterior compartment of the eye at sites analogous to the enthesis to drive ocular inflammation.


  • Open Access

    Characterization of the ocular inflammatory response to AAV reveals divergence by sex and age

    by Alison J. Clare, Philip M. Langer, Amy Ward, Ying Kai Chan, Andrew D. Dick, David A. Copland


  • Replenishing IRAK-M expression in retinal pigment epithelium attenuates outer retinal degeneration

    by Jian Liu, David A. Copland, Alison J. Clare, Mathias Gorski, Burt T. Richards, Louis Scott, Sofia Theodoropoulou, Ursula Greferath, Katherine Cox, Gongyu Shi, et al.

    Chronic inflammation is a constitutive component of many age-related diseases, including age-related macular degeneration (AMD). Here, we identified interleukin-1 receptor–associated kinase M (IRAK-M) as a key immunoregulator in retinal pigment epithelium (RPE) that declines during the aging process. Rare genetic variants ofIRAK3, which encodes IRAK-M, were associated with an increased likelihood of developing AMD. In human samples and mouse models, IRAK-M abundance in the RPE declined with advancing age or exposure to oxidative stress and was further reduced in AMD.Irak3-knockout mice exhibited an increased incidence of outer retinal degeneration at earlier ages, which was further exacerbated by oxidative stressors. The absence of IRAK-M led to a disruption in RPE cell homeostasis, characterized by compromised mitochondrial function, cellular senescence, and aberrant cytokine production. IRAK-M overexpression protected RPE cells against oxidative or immune stressors. Subretinal delivery of adeno-associated virus (AAV)–expressing humanIRAK3rescued light-induced outer retinal degeneration in wild-type mice and attenuated age-related spontaneous retinal degeneration inIrak3-knockout mice. Our data show that replenishment of IRAK-M in the RPE may redress dysregulated pro-inflammatory processes in AMD, suggesting a potential treatment for retinal degeneration.


  • Open Access

    IL-23 drives uveitis by acting on a novel population of tissue-resident entheseal T cells

    by Robert Hedley, Amy Ward, Colin J Chu, Sarah E Coupland, Serafim Kiriakidis, Peter C Taylor, Stephanie G Dakin, The ORBIT consortium, Christopher D Buckley, Jonathan Sherlock, et al.

    Recurrent acute anterior uveitis is a frequent extra-articular manifestation of the axial spondyloarthropathies (AxSpA); chronic inflammatory diseases affecting the spine, enthesis, peripheral joints, skin, and gastrointestinal tract. Pathology in AxSpA has been associated with local tissue-resident populations of interleukin (IL)-23 responsive lymphoid cells. Here we reveal a novel population of ocular T cells defined by CD3+CD4-CD8-γδTCR+IL-23R+ that reside within the anterior uvea as an ocular entheseal analogue of the mouse eye. Localised cytokine expression demonstrates that uveal IL-23R+ IL-17A-producing cells are both necessary and sufficient to drive uveitis in response to IL-23. This T cell population is also present in humans, occupying extravascular tissues of the anterior uveal compartment. Consistent with the concept of IL-23 as a unifying mediator in AxSpA, we present evidence that IL-23 can also act locally on tissue resident T cells in the anterior compartment of the eye at sites analogous to the enthesis to drive ocular inflammation.


  • Open Access

    Epigenetic drug screen identified IOX1 as an inhibitor of Th17-mediated inflammation through targeting TET2

    by Xiao Hu, Yanli Zou, David A. Copland, Lauren P. Schewitz-Bowers, Yan Li, Philippa J.P. Lait, Madeleine Stimpson, Zhihui Zhang, Shixin Guo, Juanran Liang, et al.


  • Top Cited Papers

    Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses

    by Ying Kai Chan, Sean K. Wang, Colin J. Chu, David A. Copland, Alexander J. Letizia, Helena Costa Verdera, Jessica J. Chiang, Meher Sethi, May K. Wang, William J. Neidermyer, et al.

    Incorporating TLR9-inhibitory sequences in the AAV vector genome inhibits immunogenicity and enhances transgene expression in multiple animal models.


  • Open Access

    Single Eye mRNA-Seq Reveals Normalisation of the Retinal Microglial Transcriptome Following Acute Inflammation

    by Oliver H. Bell, David A. Copland, Amy Ward, Lindsay B. Nicholson, Clemens A. K. Lange, Colin J. Chu, Andrew D. Dick

    Background: Whether retinal microglia can maintain or restore immune homeostasis during and after inflammation is unclear. We performed single-eye mRNA-sequencing on microglia at different timepoints following a single inflammatory stimulus to characterise their transcriptome during and after resolution of endotoxin-induced uveitis (EIU). Experimental Approach: Cx3cr1CreER:R26-tdTomato (C57BL/6) male heterozygotes were administered tamoxifen via different regimes at 4–5 weeks of age. Four weeks post-tamoxifen, mice were injected intravitreally with 10 ng lipopolysaccharide (endotoxin induced uveitis, EIU). Six-hundred retinal microglia were obtained by FACS from individual naïve retinas and at 4 h, 18 h, and 2 weeks following EIU induction. Samples were sequenced to a depth of up to 16.7 million reads using the SMART-Seq v4 Ultra Low Input RNA kit. The data was analysed using Partek software and Ingenuity Pathway Analysis. Genes were considered differentially-expressed (DEG) if the FDR step-up p-value was ≤0.05 and the fold-change was ≥±2. Results: Flow cytometric analysis indicates that the Cx3cr1CreER:R26-tdTomato strain is both sensitive (>95% tagging) and specific (>95% specificity) for microglia when tamoxifen is administered topically to the eye for 3 days. During “early” activation, 613 DEGs were identified. In contrast, 537 DEGs were observed during peak cellular infiltrate and none at 2 weeks, compared to baseline controls (1,069 total unique DEGs). Key marker changes were validated by qPCR, flow cytometry, and fluorescence microscopy. C5AR1 was identified and validated as a robust marker of differentiating microglial subsets during an LPS response. Conclusion: Using EIU to provide a single defined inflammatory stimulus, mRNA-Seq identified acute transcriptional changes in retinal microglia which returned to their original transcriptome after 2 weeks. Yolk-sac derived microglia are capable of restoring their homeostatic state after acute inflammation.


  • Open Access

    Intravenous indocyanine green dye is insufficient for robust immune cell labelling in the human retina

    by Oliver Hugh Bell, Ester Carreño, Emily L. Williams, Jiahui Wu, David A. Copland, Monalisa Bora, Lina Kobayter, Marcus Fruttiger, Dawn A. Sim, Richard W.J. Lee, et al.

    It is not currently possible to reliably visualise and track immune cells in the human central nervous system or eye. Previous work demonstrated that indocyanine green (ICG) dye could label immune cells and be imaged after a delay during disease in the mouse retina. We report a pilot study investigating if ICG can similarly label immune cells within the human retina. Twelve adult participants receiving ICG angiography as part of routine standard of care were recruited. Baseline retinal images were obtained prior to ICG administration then repeated over a period ranging from 2 hours to 9 days. Matched peripheral blood samples, in addition to human and mouse macrophage cultures as controls, were analysed by flow cytometry. Differences between the delayed near infrared ICG imaging and 488 nm autofluorescence was observed across pathologies, likely arising from the retinal pigment epithelium (RPE). Only one subject demonstrated ICG signal on peripheral blood myeloid cells and only three distinct cell-sized signals appeared over time within the retina of three participants. No significant increase in immune cell activation markers were detected after ICG administration. ICG accumulated in the endosomes of macrophage cultures and was detectable above a minimum concentration, suggesting cell labelling is possible. ICG can label RPE and may be used as an additional biomarker for cell health across a range of retinal disorders. Standard clinical doses of intravenous ICG do not lead to robust immune cell labelling in human blood or retina and further optimisation in dose and route are required.